Authors
Loading...
Study identifies immune evasion mechanisms and therapeutic resistance in EGFR/TP53 co-mutated NSCLC, indicating new intervention strategies.
Shi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: